Skip to main content
. 2012 Sep 18;55(12):1633–1641. doi: 10.1093/cid/cis783

Table 3.

Cox Regression Analyses of Factors Associated With First Nosocomial Infection Under Extracorporeal Membrane Oxygenation Patients

Univariate Analysis
Multivariate Analysis
Factor HR (95% CI) P Value HR (95% CI) P Value
SAPS II scorea 1.01 (.99–1.02) .09
SOFA scorea 1.05 (1.01–1.09) .03 1.04 (1.00–1.08) .05
Immunosuppressionb 1.14 (.81–1.62) .46
Reason for ECMO .38
 Miscellaneousc 1
 Myocarditis 0.84 (.49–1.44)
 Post–cardiac surgery 1.20 (.84–1.71)
Location of ECMO cannulation .09 .07
 Mobile unit 1 1
 Operating room 1.10 (.70–1.74) 1.16 (.71–1.89)
 ICU 0.59 (.35–1.01) 0.64 (.37–1.10)
Site of ECMO cannulation .85
 Intrathoracic only 1
 Extrathoracic only 0.90 (.60–1.36)
 Extrathoracic then intrathoracic 0.99 (.65–1.51)
Antibiotics at the time of ECMOd 1.07 (.76–1.51) .68 0.73 (.50–1.05) .09

Abbreviations: CI, confidence interval; ECMO, extracorporeal membrane oxygenation; HR, hazard ratio; ICU, intensive care unit; SAPS II, simplified acute physiology score; SOFA, sequential organ-failure assessment.

a Scores calculated at ICU admission. SAPS II and SOFA scores are correlated (r = 0.57; P < .0001)

b Includes patients with AIDS, solid organ transplantation, or hematological malignancy and those receiving chemotherapy, immunosuppressive agents, or long-term corticosteroid therapy.

c Includes dilated cardiomyopathy, acute myocardial infarction, cardiac arrest, and other medical indications.

d Includes patients who received prophylactic antibiotic therapy for central ECMO placement and those treated with antibiotics for an infection at the time of ECMO cannulation.